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Abstract: Bats are key species for ecological function, but they are also reservoirs of zoonotic agents,
such as lyssaviruses that cause rabies. Little is known about the maintenance and transmission of
lyssaviruses in bats, although the observation of clinically sick bats, both in experimental studies
and wild bats, has at least demonstrated that lyssaviruses are capable of causing clinical disease
in bat species. Despite this, extensive surveillance for diseased bats has not yielded lyssaviruses,
whilst serological surveys demonstrate that bats must be exposed to lyssavirus without developing
clinical disease. We hypothesize that there is endemic circulation of Lagos bat virus (LBV) in
the straw-coloured fruit bat (Eidolon helvum) in Ghana, West Africa. To investigate this further,
longitudinal blood sampling was undertaken quarterly between 2012 and 2014 on wild E. helvum
at two sites in Ghana. Serum samples were collected and tested for LBV-neutralizing antibodies
using a modified flourescent antibody virus neutralisation (FAVN) assay (n = 294) and brains from
moribund or dead bats were tested for antigen and viral RNA (n = 55). Overall, 44.7% of the 304 bats
sampled had LBV-neutralising antibodies. None of the brain samples from bats contained lyssavirus
antigen or RNA. Together with the results of an earlier serological study, our findings demonstrate
that LBV is endemic and circulates within E. helvum in Ghana even though the detection of viral
infection in dead bats was unsuccessful. Confirmation that LBV infection is endemic in E. helvum
in Ghana is an important finding and indicates that the potential public health threats from LBV
warrant further investigation.
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1. Introduction
Wildlife populations constitute a large and largely undefined reservoir of infectious agents,
some of which are zoonotic [1–3]. Infectious pathogens that originate in wild animals have become
increasingly important globally, as they have had substantial impacts on human health, agricultural
production, wildlife-based economies and wildlife conservation. Bats (Chiroptera) represent a large
group of wildlife, comprising ~20% of the 4600 mammalian species recognized to date [4]. Bats have
several key ecological functions, including pollination, seed dispersal and insect control [5]. However,
bats have also been implicated as the reservoir hosts for numerous emerging infectious diseases.
Increasingly, bats have been recognized as important reservoir hosts for viruses that have the potential
to cross species barriers to infect humans, domestic and wild mammals [4,6].
Lyssaviruses (family Rhabdoviridae, genus Lyssavirus) are the aetiological agents that cause
the disease rabies—an acute, progressive, viral encephalitis that is almost invariably fatal [7].
Most lyssaviruses are carried by bats, but the association of these viruses with bats is complex and
poorly understood [8]. Rabies virus (RABV) is found in terrestrial carnivores globally, but it is only
found in bats in the Americas, where it is endemic in frugivorous, insectivorous and hematophagous
bats [8]. In contrast, the other 13 known lyssavirus species have only been detected in the Old
World, predominantly in bat species although infection of terrestrial carnivores has been documented
for some lyssavirus species [9]. Globally, the most significant public health and veterinary burden
caused by lyssaviruses is dog-mediated transmission of RABV, but instances of other lyssavirus
infection of humans or domesticated animals have been reported on rare occasions following spill-over
events [8,10].
One bat lyssavirus that has been associated with the infection of terrestrial carnivores is Lagos bat
virus (LBV), a virus most commonly associated with infection of African fruit bats. Fruit bats of several
species have been identified as reservoir hosts for LBV, with spill-over infections reported in dogs,
cats and a mongoose [11–14]. Notably, LBV has never been reported in human cases of rabies or any
other case of human meningoencephalitis. Diagnostic tests that can differentiate between lyssaviruses
are not available in the majority of rabies endemic areas, therefore clarity surrounding the impact
of non-RABV lyssaviruses, such as LBV, is lacking. High seroprevalence against lyssaviruses has
been reported in apparently-healthy bats, including for LBV in the straw-colored fruit bat (E. helvum)
in Ghana [15]. While the ecology, pathogenesis and pathology of RABV in terrestrial animals and
humans is partially understood [7], knowledge on the other lyssavirus species is scant. In this study,
investigations into the presence of LBV infection in a natural host, E. helvum, were made through
post-mortem sampling of moribund and dead bats as well as through serological assessment of samples
for LBV neutralizing antibodies.
2. Material and Methods
2.1. Ethics Statement
The study was approved by the Institutional Review Board of the Nuguchi Memorial Institute for
Medical Research of the University of Ghana (NMIMR-ITB CPN 002/13-14 IORG0000908) and the
Ethics Committee of the Zoological Society of London (WLE/0638).
2.2. Study Sites
This study was undertaken at two E. helvum roost sites in Ghana, West Africa. The roosts
comprised between approximately 3000 to 1,000,000 bats each, depending on year and season.
One roost was located in Greater Accra (05◦35.192′ N, 000◦11.053′ W), within the grounds of a large
general infirmary (37-Military Hospital) in the center of the city. The other roost was in Tanoboase in
the Brong-Ahafo region (07◦38′ N, 01◦11.54′ W), within a protected forest area (Figure 1). The site in
Tanoboase, known locally as Tano Sacred Grove, was developed for ecotourism in 1996 and is visited
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by both local and international tourists. The site also hosts an annual Apoo festival (a time of spiritual
cleansing held in April–May).Trop. Med. Infect. Dis. 2017, 2, 25  3 of 11 
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Figure 1. Locations at which wild straw-colored fruit bats (Eidolon helvum) were captured and sampled.
2.3. Study Design
Sera Collection for Lagos Bat Virus Antibody Prevalence in Wild Eidolon helvum
Wild bats were captured using mist nets from 2012 to 2014 inclusive, as detailed in Table 1.
Sampling in June/July was aimed to correspond with late-stage pregnancy. In July, the majority
of the bats in each roost had migrated to alternative, as yet unknown, sites. By November, most
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bats had returned to each roost. Captured bats were housed individually in cloth bags for short
time periods before being processed. The sex and sexual maturity of each bat were assessed based
on body size (body mass and forearm length were measured routinely) and observation of external
genitalia and mammary tissue. Approximately 1 mL of blood was collected in micro-tubes (SARSTEDT,
Germany) from the propatagial vein of each individual, as described previously [15]. Blood samples
were centrifuged at 6000× g for 15 min and the separated sera were stored at −70 ◦C until required.
Each bat was micro-chipped (using the Trovan animal identification system, Electronic Identification
Systems, Germany) to enable identification in case of recapture. Bats were released at the site of capture
immediately following sampling, after ensuring haemostasis at the site of venipuncture.
Table 1. Sample data collected.
37-Military Hospital Tanoboase
Totals
Sampling Date 10-06-2013 04-09-2013 14-07-2014 17-12-2012 01-07-2014
Age
Adult 34 87 32 57 26 236
Juvenile 11 6 3 0 2 22
Sub-adult 0 25 11 0 0 36
Not determined 0 1 3 5 1 10
Sex
Male 34 88 30 33 25 210
Female 11 30 16 24 3 84
Unsexed 1 3 5 1 10
Serostatus
Positive 17 53 24 29 13 136
Negative 28 66 25 33 16 168
2.4. Collection and Examination of Dead Bats
Members of the public who frequented the areas under the roosts were asked to report any dead or
sick bats they found. Also, during each sampling visit, searches for dead or sick bats were undertaken
in the immediate vicinity of the roosts. Sick bats were euthanised using intramuscular ketamine and
medetomidine, followed by exsanguination via cardiac puncture. Bat carcasses were stored in a freezer
at −70 ◦C until necropsy. At necropsy, a range of tissues, including brain, was collected and stored
fixed or frozen for later investigation.
2.5. Laboratory Investigations
2.5.1. Antigen Detection Using the Fluorescent Antibody Test (FAT)
Fluorescein isothiocyanate (FITC)-conjugated anti-rabies nucleocapsid polyclonal antibody
conjugate (Fujirebio Diagnostics, Malvern, PA, USA) was used diluted 1:40 in 0.1 M phosphate
buffered saline( PBS) pH 7.2 to stain virus antigen in acetone-fixed impression smears taken from
the hippocampus, cerebellum and brain stem of bats found dead or sick (following euthanasia), as
described previously [16]. Slides were examined using a fluorescence UV microscope. LBV-infected
mouse brain material was used as a positive control for comparison of antigen distribution.
2.5.2. Detection of LBV-Neutralizing Antibodies (mFAVN)
The presence of antibodies capable of neutralizing LBV in collected bat sera was assessed using
a modified version of the fluorescent antibody virus neutralization assay (mFAVN), as described
previously [2,15]. Briefly, lineage B LBV [17] was prepared to a working concentration of 100 tissue
culture infective doses (TCID)50/50 µL. Both negative sera from an unvaccinated dog and positive
anti-LBVNig56 rabbit serum samples were used as serological controls for the assay. Each test serum
sample was diluted three-fold (starting with a 1:9 dilution) in minimum essential medium (MEM), and
incubated with the viral inoculum for 1 h at 37 ◦C before being added to BHK-21 cells in suspension in
a 96-well plate. Following incubation for 48 h at 37 ◦C, the plates were fixed in 80% chilled acetone
for 20 min, and stained with FITC-labelled anti-rabies polyclonal antibody (Fujirebio Diagnostics,
Malvern, PA, USA). Fluorescent foci present in cells infected with LBV were visualized at 488 nm using
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a fluorescence UV microscope. The lack of accurately-titred control sera meant that all neutralizing
antibody levels were expressed as D50 values. The D50 for each sample is the dilution endpoint at which
50% of the wells showed the presence of virus. D50 values were calculated using the Spearman-Karber
method. A serological cut-off was assigned according to neutralization of control sera and a back
titration of input virus.
2.5.3. Detection of LBV RNA Using Molecular Methods
Total RNA was extracted from brain tissue samples using Trizol (Invitrogen) following the
manufacturer’s protocol. A pan-lyssavirus SYBR Green real-time (q) RT-PCR [18] and a pan-lyssavirus
conventional hemi-nested-RT-PCR [19] were used to determine the presence or absence of viral RNA.
3. Statistical Analysis
The chi-squared test was used to investigate if there were significant differences in seroprevalence
according to the age, sex and roost location of bats.
4. Results
4.1. LBV Seroprevalence
Samples taken and data regarding age, sex and serology are detailed in Table 1. A total of
304 bat sera were collected and tested for LBV neutralization antibodies during the sampling periods
described. Of the 304 sera tested, 44.7% (n = 136) were considered seropositive (Table 1; Figure 2).
This comprised 213 from the 37-Military Hospital in Accra and 91 from the Tanoboase roost site,
with 236 adults, 36 sub-adults, 22 juveniles and 10 bats of undetermined age (morphometric data not
recorded); 210 males, 84 females and 10 of undetermined sex being tested across the two sites (Table 1).
Seroprevalences were high during the three years of sampling (2012—46.8%, n = 62; 2013—42.7%,
n = 164; 2014—47.4% n = 78). Of those bats that tested serologically positive, 45.2% were known
to be male (n = 95/210) while 61.9% were identified as female (n = 52/84). Results from samples
collected from bats of undetermined sex or age were not included in the statistical analyses. There
was no significant difference in the different age groups that tested positive (p-value = 0.78) (Table 2).
Seroprevalence in adult bats (0.46, n = 236) was slightly higher than in the sub-adult and juvenile bats
combined (0.43, n = 58).
Table 2. Seroprevalence in wild-caught bats by age.
Total Sampled Total Positive (% Positive)
Adult 136 109 (80.15%)
Juvenile 58 25 (43.10%)
Total 294 134 (45.57%)
In June 2013, two nursing E. helvum dams (ID: 900 and ID: 905) were caught with their pups (ID: 901
and 904, respectively) at the 37-Military Hospital roost site. All four animals were apparently healthy
with a good body condition and no outward signs of disease. Following serological assessment, the
two mothers were both seronegative with a D50 of 5.20. In contrast, both pups were seropositive with
detectable anti-LBV neutralizing antibody D50 of 46.77 and 81.00 for animals 901 and 904, respectively.
Overall, there was no statistically significant difference in seroprevalence between the two sites
(Table 1). At 37-Military Hospital, 44.1% (n = 94/213) were seropositive (Figure 2a) compared to 46.1%
(n = 42/91) of bats at Tanoboase (Figure 2b) (chi-square test = 0.04; odds ratio (OR) = 1.085; relative
risk (RR) = 1.046; p = 0.84).
To assess potential seasonal variation, an evaluation of seropositivity between the two sites
was made for each sampling time. From the total sample set obtained for the two sites, there
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was no statistical significance in the seasonal difference in seroprevalence between the dry season
(December–March) and the rainy season (April–November) (p = 0.83) (Table 3).
Table 3. Proportion of seroprevalence in wild-caught bats by season.
Positive (+ve) Negative (−ve) Total Tested
Dry Season 29 (21%) 33 (20%) 62 (20%)
Rainy Season 107 (79%) 135 (80%) 242 (80%)
Totals 136 (45%) 168 (55%) 304
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Figure 2. Serological profiles of straw-colored fruit bats sampled at (a) Tanoboase in the Brong-Ahafo
region and (b) at 37-Military Hospital, Greater Accra. Open symbols represent male bats, closed
symbols represent female bats; half-filled symbols represent bats of undetermined sex. Smaller symbols
represent juvenile or sub-adult bats. The D50 value considered the cut-off for positivity is indicated by
a dashed line.
4.2. Necropsy Findings in E. helvum Bats
Forty-six bats were examined post-mortem, of which 38 bats had been collected from the
37-Military Hospital roost and eight bats collected from Tanoboase. Thirty-three bats were found dead,
while 13 bats were found moribund and were euthanized, following clinical assessment, on welfare
grounds (Table 4). Most moribund bats (n = 11) had traumatic injuries of unknown origin. All brain
samples were negative for lyssavirus antigen and RNA using FAT and the RT-PCRs, respectively.
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Table 4. Necropsy findings in dead/moribund E. helvum bats. All bats found sick were terminated
humanely and blood taken as described.
Bat ID Location Date Found Condition Comments
A1 37-Hospital 20/01/2013 Found dead N.A.D. *
A2 37-Hospital 20/02/2013 Found dead N.A.D.
A3 37-Hospital 20/02/2013 Found dead N.A.D.
A4 37-Hospital 20/02/2013 Found dead N.A.D.
A6 37-Hospital 28/10/2013 Found dead Very enlarged spleen
A5 Accra Ridge 29/09/2013 Found dead Found dead
A12 37-Hospital 27/11/2013 Found sick Paralysed
A13 37-Hospital 27/11/2013 Found dead Fractured right arm
A7 37-Hospital 07/12/2013 Found sick Paralysis
A8 37-Hospital 07/12/2013 Found sick Paralysis
A9 37-Hospital 07/12/2013 Found dead Abscess on neck
A10 37-Hospital 10/12/2013 Found dead N.A.D.
A11 37-Hospital 08/12/2013 Found dead Fractured forearm
A14 37-Hospital 11/12/2013 Found dead Fractured forearm
A15 37-Hospital 11/12/2013 Found dead Severe intestinal, abdominal haemorrhages
A16 37-Hospital 11/12/2013 Found dead Fractured head
A17 37-Hospital 13/12/2013 Found sick Paralysis
A18 37-Hospital 13/12/2013 Found dead N.A.D.
A19 37-Hospital 13/12/2013 Found dead Punctured wing
A22 37-Hospital 22/12/2013 Found sick Paralysis, severe haemorrhages on head
A23 37-Hospital 22/12/2013 Found dead N.A.D.
A24 37-Hospital 22/12/2013 Found dead N.A.D.
A20 37-Hospital 03/01/2014 Found dead N.A.D.
A21 37-Hospital 03/01/2014 Found dead Emaciated carcass
A25 37-Hospital 22/01/2014 Found dead Fractured forearm
A26 37-Hospital 22/01/2014 Found dead Decomposed carcass
A27 37-Hospital 22/01/2014 Found dead N.A.D.
A28 37-Hospital 29/01/2014 Found dead N.A.D.
A29 37-Hospital 05/02/2014 Found dead N.A.D.
A30 37-Hospital 12/03/2014 Found dead N.A.D.
A31 37-Hospital 12/03/2014 Found dead N.A.D.
A32 37-Hospital 12/03/2014 Found dead N.A.D.
A33 37-Hospital 12/03/2014 Found dead N.A.D.
A34 37-Hospital 12/03/2014 Found dead N.A.D.
A35 37-Hospital 12/03/2014 Found dead N.A.D.
A36 37-Hospital 06/04/2014 Found sick Paralysis, emaciated
A37 37-Hospital 06/04/2014 Found sick Paralysis
A38 Achimota 09/07/2014 Found dead N.A.D.
T1 Tanoboase 22/01/2013 Found dead N.A.D.
T2 Tanoboase 22/01/2013 Found sick Fractured forearm
T3 Tanoboase 22/01/2013 Found sick Fractured forearm
T4 Tanoboase 23/01/2013 Found dead Multiple body injury
T5 Tanoboase 23/01/2013 Found sick Fractured forearm
T6 Tanoboase 07/03/2013 Found sick Weak
T7 Tanoboase 07/03/2013 Found sick Multiple body injury
T8 Tanoboase 07/03/2013 Found sick Weak
* N.A.D.—no abnormality detected
5. Discussion
A total of 304 bat sera was collected and tested for LBV neutralizing antibodies from 2012
to 2014. Of the 304 sera tested, 136 tested positive (seroprevalence: 44.7%) (Table 1; Figure 2).
Seroprevalences were high during each of the three sampling years (2012—46.8%, n = 62; 2013—42.7%,
n = 164; 2014—47.4% n = 78). These results, taken together with similar LBV serology results
reported previously [2], demonstrate the long-term endemic circulation of LBV in the Ghanaian
E. helvum population. Previous studies have reported serological evidence of exposure to LBV in
different E. helvum populations, including in Nigeria (14–44% seropositivity; n = 140), Ghana (37%
seropositivity; n = 66), and Kenya (40–67% seropositivity; n = 102) [15,17,18]. This is the first time a
previously-described seropositive population has been re-tested several years later and has been shown
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to maintain a similar level of seroprevalence. The mechanism of maintenance for lyssaviruses in bat
species with very high roost numbers and population densities is largely undefined, although several
variables including population size, contact rates, species susceptibility, immunological competence,
and roost structure may all contribute to virus maintenance via an as-yet-undefined mechanism [8,20].
The size of populations involved within the roosts studied and the movement between defined
roosts and other roosting sites that remain undefined during migratory periods may influence virus
exposure and hence seropositivity. There was no difference in seroprevalence between the two field
sites when assessing data comparing sex and age of sampled bats. However, this species is migratory
and individuals may travel long distances to feed [21] perhaps enabling interaction between E. helvum
populations and possibly also those of other bat species.
Of the 294 sera from wild-caught bats tested of known age class, 134 (45.5%) were serologically
positive for LBV neutralizing antibodies. There was no significant difference in the seroprevalence
detected between the different age groups tested. The slightly higher proportion of seropositive
adult bats (0.46) over juvenile bats (0.43) are similar to levels reported in studies addressing
serological positivity to RABV in hoary bats (Lasiurus cinereus) [22,23]. The observation of two
serologically-positive pups from dams that were serologically negative is unexplained. Maternal
antibody transfer is unlikely in the absence of detectable circulating antibodies in the dams. Whilst
both dams were seronegative, it is possible that their neutralizing antibodies were below the detection
limits of the test applied. The pups might also have acquired the antibodies from other seropositive
mothers (through allosuckling) or survived infection and thus acquired immunity.
The effect of migration and coloniality on infection dynamics is not known. Reduced migration
and population connectivity has been suggested as a mechanism that could increase the amplitude
of seasonal outbreaks and increase the probability for spillover of pathogens to other species, such
as human beings [24]. The absence of any seasonal difference in LBV seroprevalence was surprising
as increased interactions between bats, and hence an increase in pathogen transmission, might be
expected during the dry season in Ghana, when there are increased numbers and an increased
population density at the roosting sites. It is possible, though, that the bats have similar aggregation
and colonial roosting behaviors during migration as observed during the dry season in Ghana. If so,
this would account for the lack of variation in seroprevalence observed in this study.
The current understanding of lyssavirus serological positivity within bat populations is poor.
Persistence of neutralizing antibodies to lyssaviruses for longer than 12 months has been described
previously [25,26]. The long duration of antibodies detected in bats may reflect repeated exposure and
may explain the elimination of notable seasonal serological fluctuation in wild-caught bats. Such bats
will also influence the epidemiology of an outbreak in the population. From such a small sample set,
however, strong conclusions cannot be made and there is a need for a more extensive study to assess
serodynamics in bat populations.
The distribution of LBV lineages across Africa is diverse (reviewed in [8]). In Ghana, only
serological evidence of LBV has been previously reported, and then only using neutralization assays
with lineage B LBV as the test virus [2,15]. The data generated here were also based on using LBV
B as the test virus for neutralization. Future studies might benefit from assessment against all four
lineages of LBV as well as against other lyssavirus for the potential detection of cross-neutralizing
antibodies. Indeed, interpreting serological responses to lyssaviruses is problematic due to the potential
for exposure, and serological responses to, undiscovered virus(es). It is possible that further related
lyssaviruses exist, confusing the interpretation of these serological outputs. Nevertheless, numerous
bats demonstrated significant neutralizing antibody titres against the test virus. This must indicate
prior exposure to an LBV or to an antigenically-related lyssavirus.
Where higher titres are seen, it may indicate repeated exposure to antigenically-similar viruses
that drive an anamnestic response. A multiple exposure infection study with rabies virus in bats [26]
demonstrated that repeated infection may confer significant immunological memory and reduced
susceptibility to RABV infection. It is, therefore, unknown if high seroprevalence is driven by exposure
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to sub-lethal doses of LBV via routes other than biting, such as from aerosol, grooming or food sharing.
The significance of lyssavirus seropositivity in bat populations currently remains undefined.
In an attempt to detect live virus in bats at each study site, diseased and dead bats were assessed
for the presence of virus antigen and nucleic acid in brain material. Clinical signs observed in moribund
bats included paralyses, ataxia, weakness, vocalization and self-urination. The inability to detect LBV
antigen or RNA in the brain samples of moribund or dead bats supports previous findings [27]
that the infection prevalence of lyssavirus in gregarious colonial bat species is usually less than 1%
of the population. The assays used for molecular detection of viral RNA in the present study are
pan-lyssavirus in design and have been assessed to ensure that they are able to detect all lyssaviruses
described to date. Many of the necropsied bats were found with evidence of trauma and might have
been injured via intra-specific aggression, predators or human hunters; E. helvum is widely hunted
in Ghana [28]. Many bats, however, had no evidence indicating possible cause of illness or death.
A much larger sample size of dead or moribund bats may improve the chances of detecting infection
with LBV or a related lyssavirus. A similar study in Ghana with a much higher sample size (n = 567)
succeeded in isolating LBV in one E. helvum bat [29].
6. Conclusions
A high prevalence of antibodies against Lagos bat virus (LBV) in E. helvum and other bat species
was previously demonstrated in Ghana [15,30]. Further follow-up studies confirmed the endemicity
of LBV in E. helvum in Ghana [2]. The current study reports continued high antibody prevalence
levels that support earlier findings. The high seroprevalence of LBV reported previously and in this
study in apparently healthy E. helvum colonies provides evidence of long-term maintenance and
circulation of LBV in this bat population. Demonstrating the maintenance of antibody titres within
bat populations is important as it indicates that individual bats are being re-exposed to virus, which
in turn suggests that bats are shedding virus and are exposing conspecifics. Whilst this perhaps is
not surprising, demonstrating what appears to be a stable level of seroprevalence in a population
is important. The mechanisms of transmission of bat lyssaviruses remain ill-defined but minimally,
the data presented here reiterate that virus continues to circulate within the bat population, which is
important in our understanding of the relationship between bats and lyssaviruses.
Ongoing studies have indicated the occurrence of close interactions between chiropteran, domestic
animal, and human populations. Current methods used to confirm rabies virus infection in people
and terrestrial carnivores are unable to differentiate between different lyssavirus species. As human
consumption of bats is practiced in many parts of Ghana [30], the potential for human infection with
LBV exists and the invariably fatal outcome of lyssavirus infection poses questions as to the risk
from bat populations. Importantly, existing rabies vaccines do not fully protect against some African
non-rabies lyssaviruses including LBV, Mokola virus, Shimoni bat lyssavirus, Ikoma lyssavirus and
West Caucasian bat virus [31–35]; therefore an understanding of the potential risk of transmission
of these viruses to human populations is required. The results presented here are of relevance
to public health, although further information is required on LBV infection dynamics within bat
populations, potential spillover mechanisms, and bat population dynamics, to further define the risk
of human infection.
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